ARTICLE | Company News
Oxford BioMedica, Viragen, Roslin Institute deal
July 2, 2007 7:00 AM UTC
VRA will halt further development of its OVA avian transgenic technology for manufacturing therapeutic proteins and terminate related research and license agreements with OXB and the institute. OVA us...